NIH MERIT Award for Dr. Una O'Doherty
R37 MERIT Award through the National Institute of Allergy and Infectious Diseases (NIAID) for the project "Determinants of Reservoir Contraction and Expansion in vivo, ex vivo, and in vitro" in HIV antiviral therapy (ART).
Read moreConvalescent Plasma Therapy for COVID-19 Patients
Experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection is the focus of a new two-part research initiative.
Read moreCRISPR-engineered T cells in Patients with Refractory Cancer
Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published in Science by researchers from the Abramson Cancer Center.
Read moreCRISPR-engineered T cells in patients with refractory cancer
Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published by researchers from the Abramson Cancer Center.
Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia
An image from this article is featured on the cover of this edition of Blood Advances, a semimonthly medical journal published by the American Society of Hematology. The cover figure of&
Read morePenn's Gene Therapy Startup Raises Another $50 Million
Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.
Read more
